Sevelamer Carbonate Tablet, Film Coated
Product Images NDC 24979-186

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 24979-186). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Twi Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sevelamer Carbonate Chemical Structure (7397sevelamerimage 01)

Sevelamer Carbonate Chemical Structure (7397sevelamerimage 01)
Chemical structure diagram of Sevelamer Carbonate depicting the polymeric network with labeled groups including primary amine groups, crosslinking groups, and extended polymer network indicators as described in the notation below the structure.*
FDA Label Image

Figure 2 (7397sevelamerimage 02)

Figure 2 (7397sevelamerimage 02)
A line graph depicting the percentage of patients achieving a reduction of at least 2 mg/dL in serum phosphorus. The x-axis shows reduction in serum phosphorus (mg/dL), ranging from -4 to 8, with negative values indicating increase and positive values indicating reduction. The y-axis shows the percentage of patients, from 0 to 100%. Two lines are plotted comparing Sevelamer Hydrochloride and an Active Control, illustrating their respective efficacy in reducing serum phosphorus levels.*
FDA Label Image

Graph (7397sevelamerimage 03)

Graph (7397sevelamerimage 03)
A line graph depicting change in phosphorus levels from baseline over 52 weeks of treatment. Two treatment groups are shown: Sevelamer Hydrochloride and an Active Control. The vertical axis measures change in phosphorus from baseline, while the horizontal axis represents study weeks from 0 to 52.*
FDA Label Image

Twi (B5862d67 Figure 04)

FDA Label Image

Image Description (Label 800 mg)

Image Description (Label 800 mg)
Label for Sevelamer Carbonate Tablets 800 mg by TWi Pharmaceuticals, Inc. The film-coated tablets are intended for oral use and come in a package containing 270 tablets. The label includes storage instructions, manufacturer information, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.